Basis: (FMP quote price / unrounded diluted TTM EPS) / explicitly dated EPS growth percent. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-09-16T14:55:41.529Z.
Calculation as of: 2026-09-16T14:55:41.529Z.
Quote observation: 2026-09-16T14:55:05.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c8318c878184d8f15fcb7dac92ef00686d8c361da023f0ec4e261699e68c0999
PEG RATIO
N/A
Merck & Co., Inc.
Market Cap
$355.41B
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Merck & Co., Inc. (MRK) | $355.41B | N/A |
| Roche Holding AG (RHHBY)vs › | $350.98B | N/A |
| UnitedHealth Group Incorporated (UNH)vs › | $343.91B | N/A |
| AstraZeneca PLC (AZN)vs › | $252.66B | N/A |
| AbbVie Inc. (ABBV)vs › | $462.00B | N/A |
| Thermo Fisher Scientific Inc. (TMO)vs › | $239.29B | N/A |
| Amgen Inc. (AMGN)vs › | $202.45B | N/A |
| Novo Nordisk A/S (NVO)vs › | $186.26B | N/A |
| Gilead Sciences, Inc. (GILD)vs › | $183.65B | N/A |
| Abbott Laboratories (ABT)vs › | $178.09B | N/A |
PEG Ratio
N/A
P/E Ratio
115.1
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
